» Articles » PMID: 15193303

On the Neurotoxicity Mechanism of Leukoaminochrome O-semiquinone Radical Derived from Dopamine Oxidation: Mitochondria Damage, Necrosis, and Hydroxyl Radical Formation

Abstract

Leukoaminochrome o-semiquinone radical is generated during one-electron reduction of dopamine oxidation product aminochrome when DT-diaphorase is inhibited. Incubation of 100 microM aminochrome with 100 microM dicoumarol, an inhibitor of DT-diaphorase during 2 h, induces 56% cell death (P < 0.001) with concomitant formation of (i) intracellular hydroperoxides (4.2-fold increase compared to control; P < 0.001); (ii) hydroxyl radicals, detected with ESR and spin trapping agents (2.4-fold increase when cells were incubated with aminochrome in the presence of dicoumarol compared to aminochrome alone); (iii) intracellular edema, and cell membrane deterioration determined by transmission electron microscopy; (iv) absence of apoptosis, supported by using anexin-V with flow cytometry; (v) a strong decrease of mitochondrial membrane potential determined by the fluorescent dye 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanineiodide (P < 0.01); (vi) swelling and disruption of outer and inner mitochondrial membranes determined by transmission electron microscopy. These results support the proposed role of leukoaminochrome o-semiquinone radical as neurotoxin in Parkinson's disease neurodegeneration and DT-diaphorase as neuroprotective enzyme.

Citing Articles

Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease.

Huenchuguala S, Segura-Aguilar J Antioxidants (Basel). 2024; 13(9).

PMID: 39334784 PMC: 11428591. DOI: 10.3390/antiox13091125.


Rapid Metabolic Profiling of 1 μL Crude Cerebrospinal Fluid by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging Can Differentiate Parkinson's Disease.

Vallianatou T, Nilsson A, Bjarterot P, Shariatgorji R, Slijkhuis N, Aerts J Anal Chem. 2023; 95(50):18352-18360.

PMID: 38059473 PMC: 10733901. DOI: 10.1021/acs.analchem.3c02900.


Single-neuron neurodegeneration as a degenerative model for Parkinson's disease.

Huenchuguala S, Segura-Aguilar J Neural Regen Res. 2023; 19(3):529-535.

PMID: 37721280 PMC: 10581573. DOI: 10.4103/1673-5374.380878.


A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.

Segura-Aguilar J, Mannervik B Antioxidants (Basel). 2023; 12(3).

PMID: 36978921 PMC: 10045214. DOI: 10.3390/antiox12030673.


Protective Effects of Flavonoid Rutin Against Aminochrome Neurotoxicity.

De Araujo F, Frota A, de Jesus L, Cuenca-Bermejo L, Ferreira K, Santos C Neurotox Res. 2023; 41(3):224-241.

PMID: 36723781 DOI: 10.1007/s12640-022-00616-1.